Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.

ABSTRACT:

Importance

When making coverage determinations for off-label prescribing, Medicare Part D recognizes 2 compendia: the American Hospital Formulary Service (AHFS) Drug Information and the DRUGDEX Information System. Deficiencies in the accuracy and completeness of these compendia could result in coverage denials for necessary, effective, evidence-based treatments.

Objective

To evaluate these compendia for dermatologic conditions, with a focus on less common conditions that often require systemic treatment.

Design, setting, and participants

This cross-sectional study was conducted from July 1, 2018, through September 30, 2018. To identify diseases for which dermatologists may often need access to off-label systemic treatments, a list of 22 chronic, noninfectious, nonneop

SUBMITTER: Barbieri JS 

PROVIDER: S-EPMC6439906 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature